Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation

Author:

Yu TM1,Chen YH2,Lan JL2,Cheng CH3,Chen CH1,Wu MJ3,Shu KH4

Affiliation:

1. Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan

2. Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan

3. Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Internal medicine, Chung-Shan Medical University, Taichung, Taiwan

4. Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Internal medicine, Chung-Shan Medical University, Taichung, Taiwan,

Abstract

Lupus nephritis constitutes the major cause of morbidity and mortality in SLE. The long-term outcome of renal transplantation in lupus patients remains controversial, and the recurrence of lupus activity is a major concern. This study aims to determine the long-term outcome of renal transplantation in Chinese lupus patients and the evolution of lupus activity. A total of 23 lupus patients undergoing renal transplantation were enrolled and compared with 94 matched controls. The overall patient and graft survival rates at 10 years post-transplant in lupus group were not different from the control group (95.2% and 57.7% vs. 90.7% and 66.3%). Recurrence of lupus nephritis in renal allograft and flare-ups of lupus activity were not observed in this study. The SLE group had less acute rejection than the control group (20.4% vs. 29.8%, P < 0.05). The infection rate between the two groups was similar (39.1% vs. 51.1%, P = 0.427), although SLE group had a significantly higher rate of developing avascular necrosis (17.4% vs. 2.1%, P = 0.04). In conclusion, patient and graft survival rates and other major complications in Chinese lupus patients are comparable to non-lupus transplant recipients caused by other diseases. Chinese patients with SLE are suitable candidates for renal transplantation.

Publisher

SAGE Publications

Subject

Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3